NO994750D0 - Anti-Fas-antistoffer - Google Patents

Anti-Fas-antistoffer

Info

Publication number
NO994750D0
NO994750D0 NO994750A NO994750A NO994750D0 NO 994750 D0 NO994750 D0 NO 994750D0 NO 994750 A NO994750 A NO 994750A NO 994750 A NO994750 A NO 994750A NO 994750 D0 NO994750 D0 NO 994750D0
Authority
NO
Norway
Prior art keywords
fas
fas antibodies
antibodies
abnormalities
mouse
Prior art date
Application number
NO994750A
Other languages
English (en)
Other versions
NO994750L (no
Inventor
Nobufusa Serizawa
Hideyuki Haruyama
Kaori Nakahara
Ikuko Tamaki
Tohru Takahashi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO994750D0 publication Critical patent/NO994750D0/no
Publication of NO994750L publication Critical patent/NO994750L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO994750A 1998-09-30 1999-09-29 Anti-Fas-antistoffer NO994750L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27688298 1998-09-30
JP27688198 1998-09-30

Publications (2)

Publication Number Publication Date
NO994750D0 true NO994750D0 (no) 1999-09-29
NO994750L NO994750L (no) 2000-03-31

Family

ID=26552152

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994750A NO994750L (no) 1998-09-30 1999-09-29 Anti-Fas-antistoffer

Country Status (14)

Country Link
EP (1) EP0990663A3 (no)
KR (1) KR20000023549A (no)
CN (1) CN1266714A (no)
AR (1) AR023333A1 (no)
AU (1) AU757961B2 (no)
BR (1) BR9904475A (no)
CA (1) CA2283540A1 (no)
HU (1) HUP9903299A3 (no)
ID (1) ID25978A (no)
IL (1) IL132139A0 (no)
NO (1) NO994750L (no)
NZ (1) NZ500019A (no)
PL (1) PL335752A1 (no)
RU (1) RU2223115C2 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6846637B1 (en) 1998-06-18 2005-01-25 Imed Ab Fas peptides and antibodies for modulating apoptosis
WO2003080821A1 (fr) 2002-03-25 2003-10-02 Japan Science And Technology Agency Procede assurant la proliferation des hepatocytes humains et procede d'obtention d'hepatocytes humains
NZ550816A (en) * 2004-04-22 2009-12-24 Agensys Inc Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
JP5902367B2 (ja) * 2004-06-30 2016-04-13 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 抗体
HUE027099T2 (hu) * 2006-06-06 2016-08-29 Crucell Holland Bv Humán kötõmolekulák staphylococcus elleni ölõaktivitással és alkalmazásuk
JP2010512313A (ja) * 2006-12-06 2010-04-22 メディミューン，エルエルシー 全身性エリテマトーデスの治療方法
BRPI0821600A2 (pt) * 2007-12-28 2015-06-23 Bioinvent Int Ab Composição farmacêutica, artigo de fabricação, kit de partes, método de combater aterosclerose, ou uma doença cardiovascular associada à aterosclerose, e, uso de um anticorpo
RU2521669C2 (ru) * 2008-10-31 2014-07-10 Торэй Индастриз, Инк. Способ иммунологического анализа белка cxcl1 человека
DK2186829T3 (en) * 2008-11-14 2015-04-07 Canadian Blood Services Antibodies to GPIbalfa
RU2519196C2 (ru) * 2011-07-01 2014-06-10 Олег Ильич Эпштейн Лекарственное средство для лечения патологического синдрома и способ лечения рассеянного склероза
TWI660972B (zh) 2012-09-10 2019-06-01 愛爾蘭商尼歐托普生物科學公司 抗ｍｃａｍ抗體及相關使用方法
KR20160131073A (ko) 2014-03-12 2016-11-15 프로테나 바이오사이언시즈 리미티드 Lg4-5에 대해 특이적인 항-라미닌4 항체
CA2938946A1 (en) 2014-03-12 2015-09-17 Prothena Biosciences Limited Anti-mcam antibodies and associated methods of use
KR20160131082A (ko) * 2014-03-12 2016-11-15 프로테나 바이오사이언시즈 리미티드 Lg1-3에 특이적인 항-라미닌4 항체
ES2979220T3 (es) * 2015-10-23 2024-09-24 Eureka Therapeutics Inc Constructos quiméricos de anticuerpos/receptores de células T y usos de los mismos
CN111995681B (zh) * 2020-05-09 2022-03-08 华博生物医药技术（上海）有限公司 抗tigit的抗体、其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA982371B (en) * 1997-03-21 1998-09-28 Sankyo Co Humanized anti-human fas antibody
AU734758B2 (en) * 1997-04-01 2001-06-21 Sankyo Company Limited Anti-fas antibodies

Also Published As

Publication number Publication date
EP0990663A2 (en) 2000-04-05
AU5016199A (en) 2000-04-13
AR023333A1 (es) 2002-09-04
EP0990663A3 (en) 2002-04-17
CN1266714A (zh) 2000-09-20
BR9904475A (pt) 2000-12-12
NO994750L (no) 2000-03-31
KR20000023549A (ko) 2000-04-25
RU2223115C2 (ru) 2004-02-10
ID25978A (id) 2000-11-16
HU9903299D0 (en) 1999-11-29
AU757961B2 (en) 2003-03-13
HUP9903299A3 (en) 2004-05-28
PL335752A1 (en) 2000-04-10
IL132139A0 (en) 2001-03-19
CA2283540A1 (en) 2000-03-30
NZ500019A (en) 2001-06-29
HUP9903299A2 (hu) 2000-11-28

Similar Documents

Publication Publication Date Title
NO994750D0 (no) Anti-Fas-antistoffer
DE60042648D1 (de) Humanisierte anti-erbb2 antikörper und behandlung mit anti-erbb2 antikörper
DK69890D0 (da) Monoklonale antistoffer, der er reaktive med cachetin
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
TR199902803T2 (xx) VCAM-1' in te�hisinin daralt�lmas� i�in bile�ikler ve metodlar.
GR3026219T3 (en) Mouse monoclonal antibodies
DE69813839D1 (de) Verwendung von n,n-bis (phenylcarbamoylmethyl) dimethylammoniumchlorid und derivaten davon zur behandlung von chronischem schmerz
NO881051D0 (no) Metoder for behandling av solskadet, human hud med retinoider.
ID28441A (id) Terapi untuk memperbaiki kesadaran
NO981454D0 (no) Anti-FAS-antistoffer
DE3703711A1 (de) Kreuz-schuetzende monoklonale humanantikoerper und diese enthaltende mittel
TR199801321T2 (xx) Tra� b��a�� birimi.
DE69529744D1 (de) Monoklonale antikörper spezifisch gegen vaskuläres endothelzellartigen endoglyx-1, das antigen selbst und seine verwendungen
ES2061566T3 (es) Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo.
ATE189897T1 (de) Antikörper gegen das prorenin profragment, reninaktive substanz die diese enthält und prorenintest die diese verwendet
ITRM930818A0 (it) Procedimento per la produzione in piante di anticorpi ingegnerizzati, anticorpi prodotti e loro uso in diagnosi e terapia.
FI971879A0 (fi) Allogeenisten ja ksenogeenisten proteiinien vasta-aineet, niiden käyttö diagnoosissa ja hoidossa ja menetelmät niiden määrittämiseksi
TR199902410A2 (xx) Anti-Fas Antikorları
IT1233005B (it) Anticorpo umano monoclonale, composizione terapeutica che lo contiene linea cellulare capace di produrre l'anticorpo, procedimento per la sua produzione
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon
DE69102265D1 (de) Immunkomplexe.
DK0741746T3 (da) Thymosin alpha 1-analoger
BR7002742U (pt) Calcinhas e cuecas com ou sem absorventes descartaveis
KR950029205U (ko) 허리둘레의 증감을 체크할 수 있게한 팬티
ATE99332T1 (de) Monoklonale antikoerper gegen menschliche interleukin-4 und die sie erzeugenden hybridomen.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application